Amy Gaviglio

836 total citations
30 papers, 417 citations indexed

About

Amy Gaviglio is a scholar working on Clinical Biochemistry, Molecular Biology and Genetics. According to data from OpenAlex, Amy Gaviglio has authored 30 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Amy Gaviglio's work include Metabolism and Genetic Disorders (10 papers), Genomics and Rare Diseases (8 papers) and Ethics in Clinical Research (5 papers). Amy Gaviglio is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Genomics and Rare Diseases (8 papers) and Ethics in Clinical Research (5 papers). Amy Gaviglio collaborates with scholars based in United States, France and Uganda. Amy Gaviglio's co-authors include Kyriakie Sarafoglou, Amy Hietala, Mark McCann, William Thomas, Marci K. Sontag, Andrew K Ewer, Matthew E. Oster, Gerard R. Martin, Lisa A. Hom and Alex R. Kemper and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.

In The Last Decade

Amy Gaviglio

25 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Gaviglio United States 11 167 150 114 92 78 30 417
David Rodriguez‐Buritica United States 12 161 1.0× 31 0.2× 51 0.4× 54 0.6× 227 2.9× 37 429
Pao‐Chin Chiu Taiwan 12 161 1.0× 143 1.0× 70 0.6× 54 0.6× 53 0.7× 39 417
Melissa H. Fries United States 12 113 0.7× 27 0.2× 55 0.5× 28 0.3× 57 0.7× 26 471
Naoto Nishizaki Japan 10 73 0.4× 19 0.1× 46 0.4× 61 0.7× 24 0.3× 45 369
Shahana A Rahman Bangladesh 9 210 1.3× 131 0.9× 23 0.2× 28 0.3× 18 0.2× 57 399
Young‐Lim Shin South Korea 11 140 0.8× 15 0.1× 60 0.5× 61 0.7× 121 1.6× 29 400
Heves Kırmızıbekmez Türkiye 9 42 0.3× 17 0.1× 30 0.3× 26 0.3× 48 0.6× 38 263
Antonio Pepe United States 10 108 0.6× 138 0.9× 30 0.3× 31 0.3× 14 0.2× 19 413
K. Kock Denmark 10 81 0.5× 8 0.1× 48 0.4× 52 0.6× 75 1.0× 17 438
Florence Aslinia United States 6 43 0.3× 17 0.1× 37 0.3× 140 1.5× 18 0.2× 13 475

Countries citing papers authored by Amy Gaviglio

Since Specialization
Citations

This map shows the geographic impact of Amy Gaviglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Gaviglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Gaviglio more than expected).

Fields of papers citing papers by Amy Gaviglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Gaviglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Gaviglio. The network helps show where Amy Gaviglio may publish in the future.

Co-authorship network of co-authors of Amy Gaviglio

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Gaviglio. A scholar is included among the top collaborators of Amy Gaviglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Gaviglio. Amy Gaviglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaviglio, Amy, et al.. (2025). Beyond newborn screening: the role of reverse cascade testing in familial disease detection. Critical Reviews in Clinical Laboratory Sciences. 63(1). 1–11.
2.
3.
Sala‐Hamrick, Kelsey, et al.. (2025). Provider Perspectives on Implementing Trauma-Informed Approaches in Pediatric Genetics Care. Clinical Practice in Pediatric Psychology. 13(4). 419–429.
4.
Sarafoglou, Kyriakie, Amy Gaviglio, Cindy Pham Lorentz, et al.. (2024). Can Incorporating Molecular Testing Improve the Accuracy of Newborn Screening for Congenital Adrenal Hyperplasia?. The Journal of Clinical Endocrinology & Metabolism. 110(4). e1194–e1203. 1 indexed citations
5.
6.
Gaviglio, Amy, et al.. (2024). P556: Genetic providers’ views on trauma-informed care in genetics clinics. SHILAP Revista de lepidopterología. 2. 101455–101455.
7.
Gaviglio, Amy, et al.. (2023). Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020. International Journal of Neonatal Screening. 9(2). 23–23. 7 indexed citations
8.
Gaviglio, Amy, et al.. (2023). Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population. International Journal of Neonatal Screening. 9(4). 68–68. 4 indexed citations
9.
Gaviglio, Amy, et al.. (2023). Gene‐targeted therapies: Towards equitable development, diagnosis, and access. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(1). 56–63. 10 indexed citations
10.
Baker, Mei, Amy Gaviglio, Dorota Gruber, et al.. (2022). Common Challenges and Identified Solutions for State Newborn Screening Programs during COVID-19 Pandemic. International Journal of Neonatal Screening. 8(1). 7–7. 4 indexed citations
11.
Sontag, Marci K., Josh Miller, Amy Gaviglio, et al.. (2022). Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States. International Journal of Neonatal Screening. 8(3). 38–38. 15 indexed citations
12.
Goldenberg, Aaron J., et al.. (2022). Genomics and Newborn Screening: Perspectives of Public Health Programs. International Journal of Neonatal Screening. 8(1). 11–11. 12 indexed citations
13.
Gaviglio, Amy, et al.. (2021). Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA. Public Health Genomics. 24(3-4). 110–122. 3 indexed citations
14.
Wiens, Katie M., Susan A. Berry, Amy Gaviglio, et al.. (2019). A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy. American Journal of Medical Genetics Part A. 179(7). 1205–1213. 51 indexed citations
15.
Glidewell, Jill, Scott D. Grosse, Tiffany Riehle‐Colarusso, et al.. (2019). Actions in Support of Newborn Screening for Critical Congenital Heart Disease — United States, 2011–2018. MMWR Morbidity and Mortality Weekly Report. 68(5). 107–111. 29 indexed citations
16.
Bonhomme, Natasha, Scott M. Shone, Amy Gaviglio, et al.. (2019). A Newborn Screening Education Best Practices Framework: Development and Adoption. International Journal of Neonatal Screening. 5(2). 22–22. 9 indexed citations
17.
Sarafoglou, Kyriakie, et al.. (2014). Comparison of Newborn Screening Protocols for Congenital Adrenal Hyperplasia in Preterm Infants. The Journal of Pediatrics. 164(5). 1136–1140. 23 indexed citations
18.
Zawatsky, Carrie L. Blout, et al.. (2013). Newborn Screening: Education, Consent, and the Residual Blood Spot. The Position of the National Society of Genetic Counselors. Journal of Genetic Counseling. 23(1). 16–19. 6 indexed citations
19.
Sarafoglou, Kyriakie, et al.. (2012). Comparison of One-Tier and Two-Tier Newborn Screening Metrics for Congenital Adrenal Hyperplasia. PEDIATRICS. 130(5). e1261–e1268. 53 indexed citations
20.
Sarafoglou, Kyriakie, Dietrich Matern, Krista Redlinger‐Grosse, et al.. (2011). Siblings With Mitochondrial Acetoacetyl-CoA Thiolase Deficiency Not Identified by Newborn Screening. PEDIATRICS. 128(1). e246–e250. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Rodriguez‐Buritica Breakdown of academic impact, for papers by Pao‐Chin Chiu Breakdown of academic impact, for papers by Melissa H. Fries Breakdown of academic impact, for papers by Naoto Nishizaki Breakdown of academic impact, for papers by Shahana A Rahman Breakdown of academic impact, for papers by Young‐Lim Shin Breakdown of academic impact, for papers by Heves Kırmızıbekmez Breakdown of academic impact, for papers by Antonio Pepe Breakdown of academic impact, for papers by K. Kock Breakdown of academic impact, for papers by Florence Aslinia
Rankless by CCL
2026